Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled, Double-masked, Parallel Group Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Repeat Doses of Pazopanib Eye Drops in Healthy Adult Subjects
Conditions
Interventions
pazopanib
pazopanib
+2 more
Locations
1
United States
GSK Investigational Site
Glendale, California, United States
Start Date
March 9, 2010
Primary Completion Date
June 28, 2010
Completion Date
June 28, 2010
Last Updated
November 14, 2017
NCT05913063
NCT07446582
NCT06779773
NCT06990269
NCT06970665
NCT07160179
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions